Manny Pacquiao isn’t done counting his losses.
After Floyd Mayweather Jr. stuck him with a unanimous decision on Sunday (Hong Kong time), Pacquiao is facing a potential investigation — and fine or suspension — for failing to disclose a shoulder injury before the blockbuster fight.
The Nevada state attorney general’s office will investigate why Pacquiao checked “no” on questionnaire if he had a shoulder injury a day before the fight, Nevada Athletic Commission chairman Francisco Aguilar said.
“We will gather all the facts and follow the circumstances,” Aguilar said.
“At some point we will have some discussion. As a licensee of the commission, you want to make sure fighters are giving you up-to-date information.”
Pacquiao could face a possible fine or suspension for not answering the question accurately on a form he filled out just before Friday’s weigh-in, according to the Associated Press.
Meanwhile, orthopedic surgeon Dr. Neal ElAttrache told ESPN.com Pacquiao will undergo surgery later this week to repair a “significant tear” in his rotator cuff.
ElAttrache examined Pacquiao on Monday at his Kerlan Jobe Orthopedics office in Los Angeles.
On Monday, Pacquiao’s promoter put out a statement on behalf of the fighter that the injury was disclosed to the US Anti-Doping Agency (USDA), which approved the use of an anti-inflammatory shot for the fight.
But USADA was only a third party to the fight, charged only with testing the fighters for banned substances in training and the night of the bout.
“We had no medical information, no MRIs, no documents,” said Travis Tygart, who heads the USADA.
“It was not an anti-doping issue. The real question is why his camp checked ‘no’ on the disclosure. Either they made a terrible mistake to not follow the rules or they were trying not to give information to the other side. I’m not sure there’s a middle ground.”
Tygart said his agency, which was hired by promoters to oversee drug testing for the bout, was contacted April 7 asking about the use of various substances and whether they were allowed under anti-doping rules.
He said there was another call 10 days later about a different substance but the USADA was not told exactly what the treatments were for.
A little more than two hours before the fight, Pacquiao’s corner asked Nevada regulators if he could be given a shot of Toradol, an anti-inflammatory drug.
Aguilar denied it, saying the commission had no previous indication there was an injury and could not allow a shot in fairness to the Mayweather camp.
“Our job is to protect the health and safety of fighters and the integrity of the sport,” Aguilar said. “We expect our fighters to be forthright.”
Pacquiao said after the fight that his shoulder had improved and he was hopeful of fighting with the shot.
He said it didn’t bother him until the fourth round, when he hit Mayweather with a big left hand and went after him with a series of punches.
Pacquiao’s trainer, Freddie Roach, said the shoulder was getting better by the day in training camp.
“We thought at one time we’d postpone the fight, but as the weeks went on it was getting better and I was happy with his performance,” Roach said.
“I thought the progress was good enough.”
– Contact us at email@example.com